<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01876836</url>
  </required_header>
  <id_info>
    <nct_id>NCT01876836</nct_id>
  </id_info>
  <brief_title>Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications</brief_title>
  <acronym>C-LMA</acronym>
  <official_title>Comparation the Effect of C-LMA and I-gel in Regurgitation and Postoperative Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Yildirim Beyazit Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Yildirim Beyazit Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. i-gel

        2. C-LMA

      Compare the effect on gastroeosephageal reflux Postoperative complicatios.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      120 ASA I-II adult patients. Patients were randomised into two groups

        1. i-gel

        2. C-LMA Volume controlled ventilation, general anesthesia Asses Gastroeosephageal reflux,
           sore throat, coughing, dysphagia,dysphonia recorded.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ph MEASUREMENT</measure>
    <time_frame>1 MİNUTE AFTER EXTUBATİON</time_frame>
    <description>The ph of the secretions on the airway device will be measurd with a Ph-meter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleu dye on the airway device</measure>
    <time_frame>5 min after placenent</time_frame>
    <description>The airway device will be examined with fiberoptic endoscope after placement</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Blue dye on airway device</measure>
    <time_frame>1 min after extubation</time_frame>
    <description>the airway device will be examined for a precence of blue dye</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Bladder Tumour</condition>
  <condition>Prostate Hyperplasia</condition>
  <arm_group>
    <arm_group_label>i-gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>i-gel placed after induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C-LMA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>C-LMA placed after induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>i-gel</intervention_name>
    <description>i-gel placed after induction</description>
    <arm_group_label>i-gel</arm_group_label>
    <other_name>supraglottic airway device</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>C-LMA</intervention_name>
    <description>placed after induction</description>
    <arm_group_label>C-LMA</arm_group_label>
    <other_name>supraglottic airway device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II

          -  Adult

          -  Elective surgery

          -  Bladder tumour

          -  Prostat hyperplasi

        Exclusion Criteria:

          -  Emergency surgery

          -  Hiatal hernia

          -  Gastroeosephageal reflux disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reyhan Polat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reyhan Polat, MD</last_name>
    <phone>+905326734310</phone>
    <email>reyhanp9@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>DiskapiYBERH</name>
      <address>
        <city>Ankara</city>
        <state>Altındağ</state>
        <zip>06610</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Murat Alper, Prof.</last_name>
      <phone>+903125962000</phone>
      <email>muratalper@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Reyhan Polat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DiskapiYBERH</name>
      <address>
        <city>Ankara</city>
        <state>Altındağ</state>
        <zip>06610</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reyhan Polat, MD</last_name>
      <phone>+905326734310</phone>
      <email>reyhanp9@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Reyhan Polat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2013</study_first_submitted>
  <study_first_submitted_qc>June 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2013</study_first_posted>
  <last_update_submitted>June 11, 2013</last_update_submitted>
  <last_update_submitted_qc>June 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Reyhan Polat</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>i-gel</keyword>
  <keyword>C-LMA</keyword>
  <keyword>gastroeosephageal reflux</keyword>
  <keyword>sore troat</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

